CX3CL1 and Alzheimer disease: Above all, higher fractalkine concentrations were linked with higher neuroinflammation in both MCI and AD patients; perhaps blood tests to determine fractalkine levels may offer information on the disease’s evolution (Zhao et al., 2020).